Publications by authors named "Mustafa Taner Yildirmak"

Background: CoronaVac, an inactivated whole-virion SARS-CoV-2 vaccine, has been shown to be well tolerated with a good safety profile in individuals aged 18 years and older in phase 1/2 trials, and provided a good humoral response against SARS-CoV-2. We present the interim efficacy and safety results of a phase 3 clinical trial of CoronaVac in Turkey.

Methods: This was a double-blind, randomised, placebo-controlled phase 3 trial.

View Article and Find Full Text PDF

Objective: COVID-19 spread worldwide, causing severe morbidity and mortality and this process still continues. The aim of this study to investigate the prognostic value of right ventricular (RV) strain in patients with COVID-19.

Methods: Consecutive adult patients admitted to the emergency room for COVID-19 between 1 and 30 April were included in this study.

View Article and Find Full Text PDF

Objective: COVID-19 is a disease with high mortality, and risk factors for worse clinical outcome have not been well-defined yet. The aim of this study is to delineate the prognostic importance of presence of concomitant cardiac injury on admission in patients with COVID-19.

Methods: For this multi-center retrospective study, data of consecutive patients who were treated for COVID-19 between 20 March and 20 April 2020 were collected.

View Article and Find Full Text PDF

There are only few urinary schistosomiasis cases reported from Turkey. These recently diagnosed cases are either associated with overseas journeys or observed in foreign citizens visiting our country as afflicted with disease from abroad. Our case was infected when working in Africa and was diagnosed with non-Hodgkin's lymphoma of the bladder by mistake at the outset.

View Article and Find Full Text PDF